The South African Health Products Regulatory Authority has announced it will facilitate a controlled, compassionate access programme for the use of Ivermectin. The anti-parasitic drug has gained popularity over recent weeks for its supposed benefits to treat COVID-19. SAHPRA once again stressed there was not enough scientific evidence to enable a regulator to make a decision on the drug’s use.

Published on

By Smile Staff Reporter


Add Smile FM on Google

Smile Staff Reporter
Smile Staff Reporter

Latest articles

Previous article
This year’s State of the Nation address will be a virtual, hybrid sitting, with only 50 people in the National Assembly chamber. This means less pomp and ceremony. The cost-saving will be used to modernise Parliament’s technological capabilities. It will take place on 11 Feb at 7 pm.
Next article
National Treasury’s Director-General Dondo Mogajane has maintained it has the funds to secure vaccines and that finance won’t be an issue for South Africans to receive doses. The cost of vaccinating about 40 million South Africans is estimated between 20 and 24 billion rand.

Cape Town pools open daily during September school holidays!

Smile Staff Reporter -
 Cape Town’s public swimming pools will be open daily from 23 September to 5 October, giving families a chance to cool off and enjoy...

Golden Arrow to increase selected cash fares by 4.5%

Smile Staff Reporter -
  Golden Arrow bus passengers who pay cash will have to budget a little more from 28 September 2026, when selected fares increase by an...

The Tutu Memorial Park project gets underway in Cape Town

Smile Staff Reporter -
 Cape Town Mayor Geordin Hill-Lewis has this week marked the start of work on the newly renamed Tutu Memorial Park (formerly Lupin Park). This...